| scholarly article | Q13442814 |
| P50 | author | Ali Amara | Q29459055 |
| Janet M Lord | Q56014747 | ||
| John Curnow | Q56850526 | ||
| Darrell Pilling | Q69353990 | ||
| P2093 | author name string | M Salmon | |
| F Arenzana-Seisdedos | |||
| C D Buckley | |||
| E Ross | |||
| N Amft | |||
| P F Bradfield | |||
| D Scheel-Toellner | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3423-3429 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium | |
| P478 | volume | 165 |
| Q41838799 | A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis |
| Q36369352 | A coordinated change in chemokine responsiveness guides plasma cell movements |
| Q35087675 | A role for the integrin alpha6beta1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium |
| Q36061032 | A stromal address code defined by fibroblasts |
| Q35080100 | AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation |
| Q41873682 | Aggregated IgG inhibits the differentiation of human fibrocytes. |
| Q51795174 | Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. |
| Q100634388 | Analysis of gene expression from systemic lupus erythematosus synovium reveals myeloid cell-driven pathogenesis of lupus arthritis |
| Q34989354 | Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. |
| Q45042000 | Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. |
| Q42665157 | Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions |
| Q37000127 | Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor |
| Q39104422 | Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist |
| Q38909786 | Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells |
| Q56903335 | CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid |
| Q41555285 | CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis |
| Q80938435 | CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease |
| Q47894953 | CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. |
| Q50087956 | CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice |
| Q35613631 | Cell, isoform, and environment factors shape gradients and modulate chemotaxis |
| Q35138504 | Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors |
| Q34754683 | Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? |
| Q37454007 | Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. |
| Q28575108 | Chemokine receptor expression in rat adjuvant-induced arthritis |
| Q38172960 | Chemokine receptor modeling: an interdisciplinary approach to drug design |
| Q24803643 | Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 |
| Q36371105 | Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. |
| Q33909030 | Chemokines and angiogenesis in rheumatoid arthritis. |
| Q34051768 | Chemokines and chemokine receptors in arthritis |
| Q35031896 | Chemokines and chemokine receptors in rheumatoid arthritis |
| Q28200068 | Chemokines and disease |
| Q36063483 | Chemokines and their receptors in rheumatoid arthritis: future targets? |
| Q34418051 | Chemokines in autoimmune disease |
| Q35553416 | Chemokines in joint disease: the key to inflammation? |
| Q35980519 | Chemokines: control of primary and memory T-cell traffic |
| Q31144845 | Circulating CD26 is negatively associated with inflammation in human and experimental arthritis |
| Q38204265 | Crosstalk between fibroblasts and inflammatory cells |
| Q34637317 | Cytokines in rheumatoid arthritis |
| Q35916005 | Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease |
| Q93492070 | Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease |
| Q48254950 | Design, synthesis, and biological evaluation of CXCR4 ligands |
| Q47949680 | Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells. |
| Q24807287 | Differential binding of chemokines to macrophages and neutrophils in the human inflamed synovium |
| Q37689769 | Differential expression of CD148 on leukocyte subsets in inflammatory arthritis. |
| Q35058022 | Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils |
| Q24813111 | Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis? |
| Q36334083 | Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4). |
| Q36207312 | Dynamic control of lymphocyte trafficking by fever-range thermal stress |
| Q24817058 | Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin |
| Q51771694 | Elevated plasma stromal cell-derived factor 1 protein and its gene polymorphism in patients with pelvic inflammatory disease. |
| Q24793680 | Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky |
| Q84899475 | Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection |
| Q51000317 | Expression of the chemokine receptor CXCR4 on lymphocytes of leprosy patients. |
| Q36983715 | Fibroblasts as novel therapeutic targets in chronic inflammation |
| Q41935950 | Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. |
| Q34198891 | Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. |
| Q90292827 | GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretion |
| Q77982907 | Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes |
| Q61628076 | Growth Factor-like Gene Regulation Is Separable from Survival and Maturation in Antibody-Secreting Cells |
| Q47073968 | Guidance of primordial germ cell migration by the chemokine SDF-1. |
| Q24669792 | Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease |
| Q24806177 | Homing chemokines in rheumatoid arthritis. |
| Q48672266 | How the human spermatozoa sense the oocyte: a new role of SDF1-CXCR4 signalling |
| Q33510941 | Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts |
| Q37317639 | Immune interactions in hepatic fibrosis. |
| Q42071582 | Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4(+) T cells, and disease activity |
| Q54304957 | Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia. |
| Q50487851 | Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. |
| Q24299398 | Inhibition of fibrocyte differentiation by serum amyloid P |
| Q38928700 | Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells |
| Q38079237 | Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease |
| Q39546246 | Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. |
| Q37420405 | Local CXCR4 Upregulation in the Injured Arterial Wall Contributes to Intimal Hyperplasia |
| Q37378198 | Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis |
| Q41849684 | Macrophages and angiogenesis in rheumatic diseases |
| Q64108180 | Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response |
| Q27317423 | Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear |
| Q35165545 | Michael Mason prize essay 2003. Why do leucocytes accumulate within chronically inflamed joints? |
| Q60046093 | MicroRNA-31 Reduces the Motility of Proinflammatory T Helper 1 Lymphocytes |
| Q33867550 | Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography |
| Q36572543 | Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology |
| Q28198814 | Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis |
| Q33570773 | Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4. |
| Q36744611 | Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis |
| Q93017920 | Pathogenic stromal cells as therapeutic targets in joint inflammation |
| Q24642165 | Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis |
| Q36402572 | Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4. |
| Q38157897 | Physiology and pharmacology of plerixafor |
| Q35736729 | Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis |
| Q38753491 | Plasma cells as an innovative target in autoimmune disease with renal manifestations |
| Q44632542 | Post‐translational and cell type‐specific regulation of CXCR4 expression by cytokines |
| Q48179941 | Primordial germ cell migration in the chick and mouse embryo: the role of the chemokine SDF-1/CXCL12. |
| Q24812711 | Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis |
| Q51835859 | Properties and Immune Function of Cardiac Fibroblasts. |
| Q35974666 | Quantitative and qualitative characterization of expanded CD4+ T cell clones in rheumatoid arthritis patients |
| Q34031600 | Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling |
| Q34116247 | Recruitment of lymphocytes to the human liver. |
| Q35787045 | Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. |
| Q24816793 | Regulatory T cells in rheumatoid arthritis |
| Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
| Q35091583 | Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system |
| Q38221918 | SDF-1 signaling: a promising target in rheumatic diseases |
| Q44535802 | SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway |
| Q24323314 | Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines |
| Q34574987 | Small molecule inhibitors of CXCR4. |
| Q30929785 | Stromal Cell–Derived Factor-1 from Biliary Epithelial Cells Recruits CXCR4-Positive Cells: Implications for Inflammatory Liver Diseases |
| Q40741708 | Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice |
| Q40315302 | Stromal cell-derived factor 1 (SDF-1, CXCL12) is increased in subacromial bursitis and downregulated by steroid and nonsteroidal anti-inflammatory agents |
| Q94468761 | Stromal cell-derived factor 1 regulates in vitro sperm migration towards the cumulus-oocyte complex in cattle |
| Q50186474 | Stromal cell-derived factor-1 (CXCL12) activates integrins by direct binding to an allosteric ligand-binding site (site 2) of integrins without CXCR4. |
| Q41482347 | Stromal cells differentially regulate neutrophil and lymphocyte recruitment through the endothelium |
| Q77332357 | Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases |
| Q47103156 | Synovial inflammation plays a greater role in post-traumatic osteoarthritis compared to idiopathic osteoarthritis in the Hartley guinea pig knee. |
| Q26797338 | T Cell Migration in Rheumatoid Arthritis |
| Q81634736 | T cell costimulation by chemokine receptors |
| Q77381637 | TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules |
| Q34795604 | TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment |
| Q50002024 | TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells |
| Q42145272 | Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change |
| Q26770388 | Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence |
| Q38447268 | Targeting the microenvironment in acute myeloid leukemia |
| Q36472008 | Targeting the stromal microenvironment in chronic inflammation. |
| Q64071635 | The Maintenance of Memory Plasma Cells |
| Q39158831 | The Multifunctional Role of the Chemokine System in Arthritogenic Processes |
| Q90050404 | The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases |
| Q38112032 | The adventitia: Essential role in pulmonary vascular remodeling |
| Q27000503 | The adventitia: essential regulator of vascular wall structure and function |
| Q34280534 | The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells |
| Q74681840 | The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation |
| Q24535009 | The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3 |
| Q35067624 | The intricate role of CXCR4 in cancer |
| Q81163060 | The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata |
| Q36992526 | The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis |
| Q36024449 | The role of leukocyte-stromal interactions in chronic inflammatory joint disease |
| Q38075556 | The role of non-hematopoietic stromal cells in the persistence of inflammation |
| Q38063961 | The role of stromal cells in the persistence of chronic inflammation |
| Q37781917 | Therapeutic opportunities in fibroblasts in inflammatory arthritis |
| Q35180160 | Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response |
| Q37728165 | Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells |
| Q36596130 | Treating very early rheumatoid arthritis |
| Q37844776 | Why does chronic inflammation persist: An unexpected role for fibroblasts |
Search more.